Psychedelics Pharma giant AbbVie to spend over US$1B on Gilgamesh’s lead psychedelic One of the biggest deals of all time in the industry Rowan DunneAugust 27, 2025
Psychedelics Gilgamesh’s psychedelic drug demonstrates exceptional efficacy for treating depression GM-2505 is a compound with faster onset and shorter duration than psilocybin Rowan DunneMay 30, 2025